by Dr. Antonio Jiménez Jiménez
Dr. Antonio Jiménez Jiménez is the first author of the highly-cited journal article, “Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR.” He...
by Margy MacMillan
In this President’s Message, ASTCT President Margy MacMillan, MD, MSc, FRCPC, reflects on the privilege of caring for patients and the gratitude that comes from helping families navigate...
by ASTCT Advocacy Update
Congress Prepares for the Lame Duck Session
by ASTCT Talks and Oncology On the Go
In a cobranded episode between Oncology On the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, an expert...
by Yoonhee Choi, MD
In this ASTCT Committee Member Spotlight, Yoonhee Choi, MD, discusses her journey as a hematology-oncology fellow, her research in lymphoid malignancies, and her interest in cellular therapy. She...
by Miguel-Angel Perales
Miguel-Angel Perales, MD, FASTCT, is the senior author of “ASTCT Consensus Grading for Immune Effector Cell-Associated Toxicities 2026 Update.” In this Q&A, he discusses the...